首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy of ledipasvir/sofosbuvir with or without ribavirin for 12 weeks in genotype 1b HCV patients previously treated with a nonstructural protein 5A inhibitor‐containing regimen
Authors:Hiroki Ikeda  Tsunamasa Watanabe  Hirohito Shimizu  Tetsuya Hiraishi  Rena Kaneko  Toshiyuki Baba  Hideaki Takahashi  Kotaro Matsunaga  Nobuyuki Matsumoto  Hiroshi Yasuda  Chiaki Okuse  Shogo Iwabuchi  Michihiro Suzuki  Fumio Itoh
Affiliation:1. Department of Internal Medicine, Division of Gastroenterology and Hepatology, St. Marianna University, school of medicine, Kawasaki, Japan;2. Hepato‐Biliary‐Pancreatic Center, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Japan;3. Division of Gastroenterology and Hepatology, Kawasaki Municipal Tama Hospital, Kawasaki, Japan;4. Department of Gastroenterology, Japan Labour Health and Welfare Organization Kanto Rosai Hospital, Kawasaki, Japan;5. Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan;6. Division of Gastroenterology, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan
Abstract:
Keywords:hepatitis C virus  ledipasvir  nonstructural protein 5A inhibitor  P32 deletion  retreatment  ribavirin  sofosbuvir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号